NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation

[1]  N. Neff,et al.  Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs. , 2019, Cell host & microbe.

[2]  G. Núñez,et al.  Recognition of the microbiota by Nod2 contributes to the oral adjuvant activity of cholera toxin through the induction of interleukin‐1β , 2019, Immunology.

[3]  P. Rosenstiel,et al.  The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice , 2019, mBio.

[4]  R. MacLean,et al.  The evolution of antibiotic resistance , 2019, Science.

[5]  Eric J Alm,et al.  Adaptive Evolution within Gut Microbiomes of Healthy People. , 2019, Cell host & microbe.

[6]  G. Núñez,et al.  A specific gene-microbe interaction drives the development of Crohn’s disease–like colitis in mice , 2019, Science Immunology.

[7]  Wael Elhenawy,et al.  Host-Specific Adaptive Diversification of Crohn's Disease-Associated Adherent-Invasive Escherichia coli. , 2019, Cell host & microbe.

[8]  Christoph A. Merten,et al.  Antibiotics-induced monodominance of a novel gut bacterial order , 2019, Gut.

[9]  C. Streutker,et al.  Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure , 2019, Mucosal Immunology.

[10]  A. Kaser,et al.  ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS–STING , 2018, The Journal of experimental medicine.

[11]  Thomas Lengauer,et al.  Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development , 2018, Genome Medicine.

[12]  W. Lieb,et al.  The antibiotic resistome and microbiota landscape of refugees from Syria, Iraq and Afghanistan in Germany , 2018, Microbiome.

[13]  J. Raes,et al.  The resilience of the intestinal microbiota influences health and disease , 2017, Nature Reviews Microbiology.

[14]  R. Dziarski,et al.  Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction , 2017, Scientific Reports.

[15]  O. Fiehn,et al.  Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion , 2016, Nature.

[16]  R. Xavier,et al.  Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease , 2016, Science.

[17]  Martin J. Blaser,et al.  Antibiotic use and its consequences for the normal microbiome , 2016, Science.

[18]  P. Luciw,et al.  NOD1/NOD2 signaling links ER stress with inflammation , 2016, Nature.

[19]  Søren Brunak,et al.  Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci , 2016, Nature Genetics.

[20]  Ole Fröbert,et al.  The Gut Microbiota Modulates Energy Metabolism in the Hibernating Brown Bear Ursus arctos. , 2016, Cell reports.

[21]  Tim Booth,et al.  PIPITS: an automated pipeline for analyses of fungal internal transcribed spacer sequences from the Illumina sequencing platform , 2015, Methods in ecology and evolution.

[22]  Ashwin N. Ananthakrishnan,et al.  Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[23]  R. Henrik Nilsson,et al.  A Comprehensive, Automatically Updated Fungal ITS Sequence Dataset for Reference-Based Chimera Control in Environmental Sequencing Efforts , 2015, Microbes and environments.

[24]  Dan Knights,et al.  Complex host genetics influence the microbiome in inflammatory bowel disease , 2014, Genome Medicine.

[25]  P. Loke,et al.  Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. , 2014, Immunity.

[26]  M. Netea,et al.  Fungal Chitin Dampens Inflammation through IL-10 Induction Mediated by NOD2 and TLR9 Activation , 2014, PLoS pathogens.

[27]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[28]  Curtis Huttenhower,et al.  Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission , 2014, The ISME Journal.

[29]  David P. Kreil,et al.  Bacterial protein signals are associated with Crohn’s disease , 2014, Gut.

[30]  F. Bäckhed,et al.  Altered Mucus Glycosylation in Core 1 O-Glycan-Deficient Mice Affects Microbiota Composition and Intestinal Architecture , 2014, PloS one.

[31]  D. Philpott,et al.  NOD proteins: regulators of inflammation in health and disease , 2013, Nature Reviews Immunology.

[32]  Jiajie Zhang,et al.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..

[33]  R. Henrik Nilsson,et al.  Improved software detection and extraction of ITS1 and ITS2 from ribosomal ITS sequences of fungi and other eukaryotes for analysis of environmental sequencing data , 2013 .

[34]  A. Kaser,et al.  Paneth cells as a site of origin for intestinal inflammation , 2013, Nature.

[35]  F. Bushman,et al.  Fungi of the Murine Gut: Episodic Variation and Proliferation during Antibiotic Treatment , 2013, PloS one.

[36]  Hongzhe Li,et al.  Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents , 2013, PloS one.

[37]  D. Philpott,et al.  Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis , 2013, Gut microbes.

[38]  Philip Rosenstiel,et al.  NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. , 2013, The Journal of clinical investigation.

[39]  Falk Hildebrand,et al.  Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice , 2013, Genome Biology.

[40]  Nora C. Toussaint,et al.  Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization , 2013, Infection and Immunity.

[41]  E. Pamer,et al.  Antibiotics, microbiota, and immune defense. , 2012, Trends in immunology.

[42]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[43]  William A. Walters,et al.  Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. , 2012, Cell host & microbe.

[44]  K. Kidd,et al.  Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation. , 2012, Molecular biology and evolution.

[45]  Marion Leclerc,et al.  Altered gut microbiota composition in immune-impaired Nod2−/− mice , 2011, Gut.

[46]  P. Rosenstiel,et al.  Nod2 is essential for temporal development of intestinal microbial communities , 2011, Gut.

[47]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[48]  Anders F. Andersson,et al.  Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome , 2010, PloS one.

[49]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[50]  Dan Yang,et al.  A2B adenosine receptor gene deletion attenuates murine colitis. , 2008, Gastroenterology.

[51]  S. Mordon,et al.  Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. , 2008, The Journal of infectious diseases.

[52]  M. J. Cody,et al.  Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis , 2008, Innate immunity.

[53]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[54]  J. Jansson,et al.  Long-term ecological impacts of antibiotic administration on the human intestinal microbiota , 2007, The ISME Journal.

[55]  P. Rosenstiel,et al.  NOD-like receptors and human diseases. , 2007, Microbes and infection.

[56]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[57]  S Botton,et al.  Resilience of Microbial Systems Towards Disturbances , 2006, Critical reviews in microbiology.

[58]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[59]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[60]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[61]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[62]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[63]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[64]  S. Davies,et al.  Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.

[65]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[66]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[67]  J. Hanley,et al.  Statistical analysis of correlated data using generalized estimating equations: an orientation. , 2003, American journal of epidemiology.

[68]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[69]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[70]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[71]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[72]  T. Bruns,et al.  ITS primers with enhanced specificity for basidiomycetes ‐ application to the identification of mycorrhizae and rusts , 1993, Molecular ecology.

[73]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[74]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[75]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[76]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .